Back to Search Start Over

IRF2–INPP4B-mediated autophagy suppresses apoptosis in acute myeloid leukemia cells

Authors :
Feng Zhang
Jiajia Li
Junfeng Zhu
Lin Liu
Kai Zhu
Shuang Cheng
RuDi Lv
Pingping Zhang
Source :
Biological Research, Vol 52, Iss 1, Pp 1-10 (2019)
Publication Year :
2019
Publisher :
BMC, 2019.

Abstract

Abstract Background The present study aimed to investigate the underlying role of interferon-regulatory factor 2 (IRF2)–inositol polyphosphate-4-phosphatase, type-II (INPP4B) axis in the regulation of autophagy in acute myeloid leukemia (AML) cells. Methods Quantitative real time PCR (QRT-PCR) and western blot were performed to determine the expression levels of IRF2, INPP4B and autophagy-related markers in AML cell lines. Autophagy was assessed by elevated Beclin-1 expression, the conversion of light chain 3 (LC3)-I to LC3-II, downregulated p62 expression and green fluorescent protein (GFP)-LC3 puncta formation. The colony formation and apoptosis assays were performed to determine the effects of IRF2 and INPP4B on the growth of AML cells. Results IRF2 and INPP4B were highly expressed in AML cell lines, and were positively correlated with autophagy-related proteins. Overexpression of IRF2 or INPP4B stimulated autophagy of AML cells, whereas inhibition of IRF2 or INPP4B resulted in the attenuation of autophagy. More importantly, IRF2 or INPP4B overexpression reversed autophagy inhibitor, 3-methyladenine (3-MA)-induced proliferation-inhibitory and pro-apoptotic effects, while IRF2 or INPP4B silencing overturned the proliferation-promoting and anti-apoptotic effects of autophagy activator rapamycin. Conclusion IRF2–INPP4B signaling axis attenuated apoptosis through induction of autophagy in AML cells.

Details

Language :
English
ISSN :
07176287
Volume :
52
Issue :
1
Database :
Directory of Open Access Journals
Journal :
Biological Research
Publication Type :
Academic Journal
Accession number :
edsdoj.6211e300ab404ba3bc45c21b687ed407
Document Type :
article
Full Text :
https://doi.org/10.1186/s40659-019-0218-7